By adding eligibility to people 65 and older and others with high-risk conditions, Pennsylvania expanded the size of the Phase 1A vaccine group from 900,000 to nearly 3.5 million residents, according to an estimate by Ariadne Labs. Shown below is a breakdown of the estimated original and expanded 1A eligible totals by local counties.